No profile data available.
Bio-Path Holdings, Inc. (BPTH) is a healthcare company in the blood cancer treatment drugs industry, based in Bellaire, United States, with about 1 full-time employees.
In Q3 2025 (the quarter ended September 30, 2025) revenue was $0. Its market capitalization was $10,059 as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2024; market data as of October 9, 2026.
Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nanoparticle drug development company in the United States.
$10,059 as of October 9, 2026.
Listed companies of a similar size in the same industry (blood cancer treatment drugs) include Alaunos Therapeutics, Inc. (TCRT), CERo Therapeutics Holdings, Inc. (CERO), Vincerx Pharma, Inc. (VINC).